SCHEMBL1677666

SCHEMBL1677666

[CH2]/C=C/C=C/C=C/[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1542069 1.00
SCHEMBL43443 0.94
SCHEMBL7924393 0.82
SCHEMBL236557 0.82
SCHEMBL19973748 0.82
SCHEMBL7924391 0.82
SCHEMBL236556 0.82
SCHEMBL19973744 0.82
SCHEMBL19973793 0.78 ALDH1A1 (0.44)
SCHEMBL233994 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4349366-A1 PHARMACEUTICAL COMPOSITION Mie University (JP) 2024-04-10 EP disclosed
WO-2024019127-A1 HYALURONIC ACID DERIVATIVE PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION 旭化成株式会社 2024-01-25 WO disclosed
WO-2024019118-A1 HYALURONIC ACID DERIVATIVE DRUG COMPOSITION AND DRUG COMPOSITION 旭化成株式会社 2024-01-25 WO disclosed
WO-2023234376-A1 HYALURONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION 旭化成株式会社 2023-12-07 WO disclosed
US-20230085879-A1 HYALURONIC ACID DERIVATIVE COMPOSITION, PHARMACEUTICAL COMPOSITION AND HYALURONIC ACID DERIVATIVE-DRUG CONJUGATE COMPOSITION ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-03-23 US disclosed
US-20230066990-A1 HYALURONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND HYALURONIC ACID DERIVATIVE-DRUG COMPLEX ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-03-02 US disclosed
US-11564971-B2 Hyaluronic acid derivative having amino acid and steryl group introduced thereinto CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-01-31 US disclosed
EP-4101860-A1 HYALURONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND HYALURONIC ACID DERIVATIVE-DRUG CONJUGATE Asahi Kasei Kabushiki Kaisha (JP) 2022-12-14 EP disclosed
EP-4101466-A1 HYALURONIC ACID DERIVATIVE COMPOSITION, PHARMACEUTICAL COMPOSITION AND HYALURONIC ACID DERIVATIVE-DRUG CONJUGATE COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2022-12-14 EP disclosed
WO-2022255384-A1 PHARMACEUTICAL COMPOSITION 国立大学法人三重大学 2022-12-08 WO disclosed
EP-2894173-A1 HYALURONIC ACID DERIVATIVE HAVING AMINO ACID AND STERYL GROUP INTRODUCED THEREINTO Chugai Seiyaku Kabushiki Kaisha (JP) 2015-07-15 EP disclosed
EP-2360188-B1 HYALURONIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF NAT UNIV CORP TOKYO MED & DENT (JP) 2014-09-17 EP disclosed
US-8759322-B2 Hyaluronic acid derivative and pharmaceutical composition thereof NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (JP) 2014-06-24 US disclosed
US-20110212901-A1 HYALURONIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNVERSITY (JP) 2011-09-01 US disclosed
EP-2360188-A1 HYALURONIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF National University Corporation Tokyo Medical and Dental University (JP) 2011-08-24 EP disclosed
US-20110098305-A1 ARYLSULFONAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE BAELL JONATHAN BAYLDON 2011-04-28 US disclosed
US-7018993-B2 Antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-03-28 US disclosed
US-20030158164-A1 Novel antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-21 US disclosed
EP-1304334-A1 NOVEL ANTIANDROGENIC AGENT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-23 EP disclosed
EP-1219631-A1 ANTIANDROGEN AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-07-03 EP disclosed